Clearance of carbapenemase-producing Enterobacteriaceae (CPE) carriage: a comparative study of NDM-1 and KPC CPE

被引:23
|
作者
Lim, Y. J. [1 ]
Park, H. Y. [1 ]
Lee, J. Y. [1 ]
Kwak, S. H. [1 ]
Kim, M. N. [2 ]
Sung, H. [2 ]
Kim, S. -H. [1 ,3 ]
Choi, S. H. [1 ,3 ]
机构
[1] Asan Med Ctr, Off Infect Control, Seoul, South Korea
[2] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Lab Med, Seoul, South Korea
[3] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Infect Dis, 88 Olymp Ro,443 Gil, Seoul 138736, South Korea
关键词
Carbapenemase; Carbapenemase-producing; Enterobacteriaceae; KPC; NDM; LONG-TERM CARRIAGE; KLEBSIELLA-PNEUMONIAE; ESCHERICHIA-COLI; COLONIZATION; KOREA;
D O I
10.1016/j.cmi.2018.05.013
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objectives: The aim of this study was to compare clearance rates and related characteristics of patients carrying KPC-producing carbapenemase-producing Enterobacteriaceae (CPE) with those of patients carrying NDM-1-producing CPE. Methods: From November 2010 to October 2016, consecutive patients whose clinical or surveillance cultures yielded CPE were prospectively identified and followed in a 2700-bed tertiary referral hospital. CPE control protocols included strict single-room isolation, contact precautions and weekly surveillance cultures. CPE clearance was defined as three or more consecutive CPE-negative cultures without relapse. We compared patients carrying NDM-1 CPE and KPC and those with and without clearance. The time to CPE clearance or discharge was assessed using the Kaplan-Meier method and NDM-1 CPE and KPC CPE groups were compared. Results: A total of 147 patients carrying CPE, 106 with NDM-1 and 41 with KPC, were included in the study. At the time of hospital discharge, 12 of the 106 patients carrying NDM-1 CPE were clear of CPE, whereas none of the KPC CPE patients were (NDM-1, 11.3% (12/106) versus KPC, 0% (0/41), p 0.02). There was no significant association between CPE clearance and factors such as an immunocompromised condition, antibiotic usage, or species of colonizing organism. Among 40 patients who were readmitted, CPE non-clearance was significantly higher in patients carrying KPC CPE (NDM-1, 36.7% (11/30) versus KPC, 80.0% (8/10), p 0.03). Conclusions: Compared with NDM-1 CPE patients, patients carrying KPC CPE had a significantly lower probability of clearance during hospitalization. Furthermore, KPC CPE carriage persisted for a substantial period of time following patient discharge. (C) 2018 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:1104.e5 / 1104.e8
页数:4
相关论文
共 50 条
  • [31] Acetic acid as a decontamination method for ICU sink drains colonized by carbapenemase-producing Enterobacteriaceae and its effect on CPE infections
    Smolders, D.
    Hendriks, B.
    Rogiers, P.
    Mul, M.
    Gordts, B.
    JOURNAL OF HOSPITAL INFECTION, 2019, 102 (01) : 82 - 88
  • [32] Reflections on a national public health emergency response to carbapenemase-producing Enterobacterales (CPE)
    Humphreys, Hilary
    Cormican, Martin
    Brennan, Wendy
    Burns, Karen
    O'Donovan, Diarmuid
    Dalchan, Therese
    Keane, Shirley
    Sheahan, Anne
    EPIDEMIOLOGY AND INFECTION, 2022, 150
  • [33] Comparison of nine different selective agars for the detection of carbapenemase-producing Enterobacterales (CPE)
    Goettig, Stephan
    Walker, Sarah, V
    Saleh, Ahmad
    Koroska, Florian
    Sommer, Julian
    Stelzer, Yvonne
    Steinmann, Joerg
    Hamprecht, Axel
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2020, 39 (05) : 923 - 927
  • [34] Risk Factors and Outcomes of Patients Colonized with KPC and NDM Carbapenemase-Producing Enterobacterales
    Saidel-Odes, Lisa
    Sagi, Orli
    Troib, Shani
    Hannah, Leeman
    Nativ, Ronit
    Schlaeffer-Yosef, Tal
    Azulay, Hovav
    Nesher, Lior
    Borer, Abraham
    ANTIBIOTICS-BASEL, 2024, 13 (05):
  • [35] In vitro activity of mecillinam against Enterobacteriaceae with NDM-1 carbapenemase
    Marrs, Emma C. L.
    Day, Kathryn M.
    Perry, John D.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2014, 69 (10) : 2873 - 2875
  • [36] NDM-1 Carbapenemase-Producing Enterobacteriaceae are Highly Susceptible to Ceragenins CSA-13, CSA-44, and CSA-131
    Chmielewska, Sylwia Joanna
    Sklodowski, Karol
    Piktel, Ewelina
    Suprewicz, Lukasz
    Fiedoruk, Krzysztof
    Daniluk, Tamara
    Wolak, Przemyslaw
    Savage, Paul B.
    Bucki, Robert
    INFECTION AND DRUG RESISTANCE, 2020, 13 : 3277 - 3294
  • [37] Probabilistic microsimulation to examine the cost-effectiveness of hospital admission screening strategies for carbapenemase-producing enterobacteriaceae (CPE) in the United Kingdom
    Manoukian, Sarkis
    Stewart, Sally
    Dancer, Stephanie J.
    Mason, Helen
    Graves, Nicholas
    Robertson, Chris
    Leonard, Alistair
    Kennedy, Sharon
    Kavanagh, Kim
    Parcell, Benjamin
    Reilly, Jacqui
    EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2022, 23 (07): : 1173 - 1185
  • [38] Probabilistic microsimulation to examine the cost-effectiveness of hospital admission screening strategies for carbapenemase-producing enterobacteriaceae (CPE) in the United Kingdom
    Sarkis Manoukian
    Sally Stewart
    Stephanie J. Dancer
    Helen Mason
    Nicholas Graves
    Chris Robertson
    Alistair Leonard
    Sharon Kennedy
    Kim Kavanagh
    Benjamin Parcell
    Jacqui Reilly
    The European Journal of Health Economics, 2022, 23 : 1173 - 1185
  • [39] Comparative risk factors for nosocomial New Delhi metallo-beta-lactamase (NDM-1) producing Enterobacteriaceae and non-carbapenemase producing (NCP) Enterobacteriaceae
    E Izharuddin
    K Marimuthu
    P Bee Fong
    K Jia Qi
    A Chow
    DC Lye
    P Krishnan
    B Ang
    Antimicrobial Resistance and Infection Control, 4 (Suppl 1)
  • [40] Rapid Detection of Carbapenemase-producing Enterobacteriaceae From Blood Culture Bottles of Known CPE Carriers Real-world Experience
    Kriger, Or
    Shatzman-Steuerman, Rachel
    Smollan, Gillian
    Belausov, Natasha
    Sarkisian, Gayane
    Amit, Sharon
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2022, 41 (01) : 45 - 47